STERIS plc (STE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 204.00 |
| Open | 206.12 |
| Bid | 80.91 x 1100 |
| Ask | 0.00 x 800 |
| Day's range | 200.93 - 207.85 |
| 52-week range | 180.54 - 254.00 |
| Volume | |
| Avg. volume | 455,966 |
| Market cap | 19.882B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 35.36 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.08 (1.03%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- Zacks
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.
- Zacks
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
- Zacks
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2024 Yahoo. All rights reserved.